Loading...

Virologic Response, Early HIV-1 Decay and Maraviroc Pharmacokinetics with the Nucleos(t)ide-free Regimen of MaravIroc plus Darunavir/ritonavir in a Pilot Study

OBJECTIVE: To address the need for nucleos(t)ide reverse transcriptase inhibitor (NRTI)-sparing regimens, we explored the virologic and pharmacokinetic characteristics of maraviroc plus ritonavir-boosted darunavir in a single-arm, open-label, 96-week study. METHODS: 24 antiretroviral-naïve R5 HIV-1-...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Taiwo, Babafemi, Acosta, Edward P, Ryscavage, Patrick, Berzins, Baiba, Lu, Darlene, Lalezari, Jay, Castro, Jose, Adeyemi, Oluwatoyin, Kuritzkes, Daniel R., Eron, Joseph J., Tsibris, Athe, Swindells, Susan
Format: Artigo
Sprog:Inglês
Udgivet: 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4208821/
https://ncbi.nlm.nih.gov/pubmed/23797691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3182a03d95
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!